Trials / Completed
CompletedNCT03881722
Effect of Magnesium Alginate in Infants With Gastroesophageal Reflux.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 89 (actual)
- Sponsor
- Policlinico Hospital · Academic / Other
- Sex
- All
- Age
- 3 Weeks – 1 Year
- Healthy volunteers
- Accepted
Summary
Recurrent regurgitation stress the infants and their parents and often results in an inappropirate use of PPI prescription in infancy. The aim of this study is to evaluate the efficacy of Mg alginate in infants with symptoms of gastroesophageal reflux.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Mg alginate | Mg alginate after feedings |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2018-12-01
- Completion
- 2018-12-01
- First posted
- 2019-03-19
- Last updated
- 2019-03-19
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT03881722. Inclusion in this directory is not an endorsement.